Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 3 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of SIX4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 763.82 | 243 / 245 | 99% | 11.21 | 499 / 502 |
ovary | 99% | 395.52 | 179 / 180 | 99% | 14.98 | 426 / 430 |
breast | 80% | 173.17 | 366 / 459 | 97% | 14.01 | 1081 / 1118 |
pancreas | 100% | 256.70 | 327 / 328 | 66% | 3.37 | 118 / 178 |
thymus | 100% | 339.29 | 651 / 653 | 66% | 4.42 | 400 / 605 |
uterus | 80% | 184.34 | 136 / 170 | 81% | 8.86 | 371 / 459 |
lung | 67% | 200.82 | 387 / 578 | 89% | 9.39 | 1029 / 1155 |
bladder | 71% | 196.14 | 15 / 21 | 67% | 4.89 | 339 / 504 |
esophagus | 61% | 109.80 | 875 / 1445 | 78% | 8.71 | 142 / 183 |
stomach | 97% | 317.32 | 350 / 359 | 33% | 1.75 | 95 / 286 |
brain | 63% | 118.78 | 1654 / 2642 | 51% | 2.14 | 357 / 705 |
adrenal gland | 95% | 218.35 | 245 / 258 | 14% | 0.54 | 32 / 230 |
muscle | 100% | 2583.61 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.01 | 1 / 1 |
kidney | 84% | 142.69 | 75 / 89 | 12% | 0.88 | 110 / 901 |
blood vessel | 91% | 219.35 | 1211 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 7.80 | 35 / 45 |
adipose | 75% | 151.72 | 902 / 1204 | 0% | 0 | 0 / 0 |
skin | 37% | 323.42 | 666 / 1809 | 24% | 1.03 | 114 / 472 |
intestine | 34% | 48.04 | 326 / 966 | 25% | 1.28 | 131 / 527 |
heart | 50% | 74.89 | 427 / 861 | 0% | 0 | 0 / 0 |
liver | 2% | 2.24 | 5 / 226 | 9% | 0.31 | 37 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
peripheral blood | 3% | 3.55 | 24 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0060037 | Biological process | pharyngeal system development |
GO_0030238 | Biological process | male sex determination |
GO_0072107 | Biological process | positive regulation of ureteric bud formation |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0061197 | Biological process | fungiform papilla morphogenesis |
GO_0072095 | Biological process | regulation of branch elongation involved in ureteric bud branching |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0046661 | Biological process | male sex differentiation |
GO_0032880 | Biological process | regulation of protein localization |
GO_0030910 | Biological process | olfactory placode formation |
GO_0061551 | Biological process | trigeminal ganglion development |
GO_0043586 | Biological process | tongue development |
GO_0048699 | Biological process | generation of neurons |
GO_0072075 | Biological process | metanephric mesenchyme development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0050678 | Biological process | regulation of epithelial cell proliferation |
GO_0034504 | Biological process | protein localization to nucleus |
GO_0048538 | Biological process | thymus development |
GO_0090190 | Biological process | positive regulation of branching involved in ureteric bud morphogenesis |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0098528 | Biological process | skeletal muscle fiber differentiation |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0008584 | Biological process | male gonad development |
GO_0048701 | Biological process | embryonic cranial skeleton morphogenesis |
GO_1902725 | Biological process | negative regulation of satellite cell differentiation |
GO_0045214 | Biological process | sarcomere organization |
GO_0051451 | Biological process | myoblast migration |
GO_0008582 | Biological process | regulation of synaptic assembly at neuromuscular junction |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0061055 | Biological process | myotome development |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
Gene name | SIX4 |
Protein name | Homeobox protein SIX4 (Sine oculis homeobox homolog 4) SIX homeobox 4 |
Synonyms | |
Description | FUNCTION: Transcriptional regulator which can act as both a transcriptional repressor and activator by binding a DNA sequence on these target genes and is involved in processes like cell differentiation, cell migration and cell survival. Transactivates gene expression by binding a 5'-[CAT]A[CT][CT][CTG]GA[GAT]-3' motif present in the Trex site and a 5'-TCA[AG][AG]TTNC-3' motif present in the MEF3 site of the muscle-specific genes enhancer. Acts cooperatively with EYA proteins to transactivate their target genes through interaction and nuclear translocation of EYA protein. Acts synergistically with SIX1 to regulate target genes involved in formation of various organs, including muscle, kidney, gonad, ganglia, olfactory epithelium and cranial skeleton. Plays a role in several important steps of muscle development. Controls the genesis of hypaxial myogenic progenitors in the dermomyotome by transactivating PAX3 and the delamination and migration of the hypaxial precursors from the ventral lip to the limb buds through the transactivation of PAX3, MET and LBX1. Controls myoblast determination by transactivating MYF5, MYOD1 and MYF6. Controls somitic differentiation in myocyte through MYOG transactivation. Plays a role in synaptogenesis and sarcomere organization by participating in myofiber specialization during embryogenesis by activating fast muscle program in the primary myotome resulting in an up-regulation of fast muscle genes, including ATP2A1, MYL1 and TNNT3. Simultaneously, is also able to activate inhibitors of slow muscle genes, such as SOX6, HRASLS, and HDAC4, thereby restricting the activation of the slow muscle genes. During muscle regeneration, negatively regulates differentiation of muscle satellite cells through down-regulation of MYOG expression. During kidney development regulates the early stages of metanephros development and ureteric bud formation through regulation of GDNF, SALL1, PAX8 and PAX2 expression. Plays a role in gonad development by regulating both testis determination and size determination. In gonadal sex determination, transactivates ZFPM2 by binding a MEF3 consensus sequence, resulting in SRY up-regulation. In gonadal size determination, transactivates NR5A1 by binding a MEF3 consensus sequence resulting in gonadal precursor cell formation regulation. During olfactory development mediates the specification and patterning of olfactory placode through fibroblast growth factor and BMP4 signaling pathways and also regulates epithelial cell proliferation during placode formation. Promotes survival of sensory neurons during early trigeminal gangliogenesis. In the developing dorsal root ganglia, up-regulates SLC12A2 transcription. Regulates early thymus/parathyroid organogenesis through regulation of GCM2 and FOXN1 expression. Forms gustatory papillae during development of the tongue. Also plays a role during embryonic cranial skeleton morphogenesis. . |
Accessions | ENST00000556952.3 Q9UIU6 G3V2N2 ENST00000216513.5 |